- Home
- SVT vs NNVC Comparison
SVT vs NNVC Comparison
Compare SVT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- NNVC
- Stock Information
- Founded
- SVT 1959
- NNVC 2005
- Country
- SVT United States
- NNVC United States
- Employees
- SVT N/A
- NNVC N/A
- Industry
- SVT Industrial Machinery/Components
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- SVT Consumer Discretionary
- NNVC Health Care
- Exchange
- SVT Nasdaq
- NNVC Nasdaq
- Market Cap
- SVT 27.1M
- NNVC 22.0M
- IPO Year
- SVT N/A
- NNVC N/A
- Fundamental
- Price
- SVT $10.60
- NNVC $1.50
- Analyst Decision
- SVT
- NNVC Strong Buy
- Analyst Count
- SVT 0
- NNVC 1
- Target Price
- SVT N/A
- NNVC $6.50
- AVG Volume (30 Days)
- SVT 1.7K
- NNVC 323.3K
- Earning Date
- SVT 03-21-2025
- NNVC 02-14-2025
- Dividend Yield
- SVT N/A
- NNVC N/A
- EPS Growth
- SVT N/A
- NNVC N/A
- EPS
- SVT 0.05
- NNVC N/A
- Revenue
- SVT $47,487,000.00
- NNVC N/A
- Revenue This Year
- SVT N/A
- NNVC N/A
- Revenue Next Year
- SVT N/A
- NNVC N/A
- P/E Ratio
- SVT $223.96
- NNVC N/A
- Revenue Growth
- SVT 19.50
- NNVC N/A
- 52 Week Low
- SVT $10.16
- NNVC $1.03
- 52 Week High
- SVT $13.85
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- SVT 47.50
- NNVC 63.26
- Support Level
- SVT $10.26
- NNVC $1.30
- Resistance Level
- SVT $10.66
- NNVC $1.47
- Average True Range (ATR)
- SVT 0.34
- NNVC 0.11
- MACD
- SVT -0.04
- NNVC 0.04
- Stochastic Oscillator
- SVT 36.50
- NNVC 88.37
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.